Fatty liver disease, also called metabolic dysfunction-associated steatohepatitis (MASH), is a condition where fat ...

Novo Nordisk A/S' Q1 earnings reveal strong growth in semaglutide-driven sales despite a slight revenue miss. Learn more ...

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

Findings showed a 13.6% reduction in body weight in the semaglutide 25 mg group compared with a 2.2% reduction in the placebo group.

The risk for ocular problems linked to different formulations of semaglutide appear to vary, according to a new study, which ...

An international study led by the director of Virginia Commonwealth University’s liver institute suggests that ...

Semaglutide may be prescribed for different reasons and some forms may be more suitable for you than others: Ozempic. Ozempic is approved by the FDA (U.S. Food and Drug Administration) for type 2 ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

The New England Journal of Medicine (NEJM) published results from part 1 of the ongoing phase 3 ESSENCE trial which ...

Brigham Buhler, a MAHA influencer and biotech entrepreneur, has Robert F. Kennedy’s ear. But will RFK listen to his call to ...